Recent advances in neuroimaging have highlighted the interest to differentiate hippocampal
subfields for cognitive neurosciences and more notably in assessing the effects of normal …

Hippocampal atrophy, as evidenced using magnetic resonance imaging (MRI), is one of the
most validated, easily accessible and widely used biomarkers of Alzheimer's disease (AD) …

In the present study, we investigated whether hippocampal subfields (cornu ammonis 1-3,
dentate gyrus, and subiculum) and anteroposterior hippocampal subregions (head, body …

In the past few years, there has been an increasing awareness of the regional vulnerability
of the hippocampus to age‐related processes. However, to date, no studies have assessed …

Hippocampal atrophy in advanced healthy aging has frequently been reported. However,
the vulnerability of different hippocampal subfields to age‐related atrophy is still a source of …

The hippocampus has been extensively studied in various neuropsychiatric disorders
throughout the lifespan. However, inconsistent results have been reported with respect to …

The measurement of hippocampal volumes using MRI is a useful in-vivo biomarker for
detection and monitoring of early Alzheimer's disease (AD), including during the amnestic …

Histological studies have suggested differing involvement of the hippocampal subfields in
ageing and in Alzheimer's disease. The aim of this study was to assess in vivo local …

Background The hippocampus and hippocampal subfields have been found to be diversely
affected in Alzheimer's Disease (AD) and early stages of Alzheimer's disease by …

Animal and human autopsy studies suggest that subfields of the hippocampal formation are
differentially affected by neuropsychiatric diseases. Therefore, subfield volumes may be …